CALCIUM SUPPLEMENTATION AND REDUCTION IN ASSOCIATED FRACTURES IN MEDICAID OSTEOPOROSIS PATIENTS

Author(s)

Dodd MA, Shah BM, Gupchup GV, Anderson JR, The University of New Mexico, Albuquerque, NM, USA

OBJECTIVES: To increase calcium supplementation in Medicaid patients diagnosed with or at high risk for osteoporosis. To reduce the number of osteoporosis associated bone fractures. To determine if mailing to the patient only or the patient and their health care provider is more effective in changing calcium prescribing. METHODS: New Mexico Medicaid fee-for-service patients with prescription claims for osteoporosis or chronic oral steroid therapy without prescription claims for calcium supplementation from October 2000 through February 2001 were identified. The state was divided into 4 geographical regions. These regions were randomly assigned to the following intervention groups: 1) patient only, 2) patient and prescriber, 3) patient and community pharmacy, 4) patient, prescriber, and community pharmacy. The patients and their health care providers were mailed osteoporosis and calcium educational materials according to their group. The prescription claims database was reviewed 3 months following the mailing for new calcium prescription claims. Based on a previous epidemiologic study and Medicare reimbursement for hip fractures, a cost analysis was performed. RESULTS: A total of 1,094 patients, 239 prescribers, and 108 community pharmacies were included in the intervention. Three months following the mailing 10.6% (n=109) of the remaining eligible patients had calcium prescription claims. Calcium prescription claims were present for 6.9%, 8.4%, 10.2%, and 16.6% of the patients in groups 1, 2, 3, and 4, respectively. Hip fracture associated hospital costs of $10,780 will potentially be saved by avoiding 1.33 hip fractures per year. Net savings of $4357 will potentially be achieved. CONCLUSIONS: Educational materials mailed to the patient, prescriber, and community pharmacy resulted in the highest change in therapy. The addition of calcium supplementation to osteoporosis patients' drug therapy can potentially result in significant cost savings and avoid hospitalizations.

Conference/Value in Health Info

2002-05, ISPOR 2002, Arlington, VA, USA

Value in Health, Vol. 5, No. 3 (May/June 2002)

Code

PAO18

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Hospital and Clinical Practices

Disease

Musculoskeletal Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×